Dow Jones

38 778,10

0,49%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Ohr Pharmaceuticals, Inc. (OHRP)
Ohr Pharmaceuticals, Inc. (OHRP) Actualités

OHRP

Ohr Pharmaceuticals, Inc. (OHRP)

Ohr Pharmaceuticals, Inc.

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:OHRP

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
03/10/2019	23h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
24/09/2019	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
23/09/2019	23h06	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
13/09/2019	23h19	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
27/08/2019	16h03	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
16/08/2019	23h02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
14/08/2019	23h12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
23/07/2019	15h59	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
17/07/2019	23h27	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
11/07/2019	23h28	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
03/07/2019	16h00	GlobeNewswire Inc.	Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
07/06/2019	16h28	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
03/06/2019	23h22	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
15/05/2019	22h01	GlobeNewswire Inc.	Ohr Pharmaceutical Reports Financial Results for the Fiscal Second Quarter of 2019	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
08/03/2019	23h21	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
21/02/2019	16h45	GlobeNewswire Inc.	Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
09/01/2019	21h45	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Ohr Pharmaceutical, Inc.	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
04/01/2019	13h40	PR Newswire (US)	LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
03/01/2019	16h36	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
31/12/2018	22h38	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
18/12/2018	23h05	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
07/12/2018	22h10	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
14/08/2018	22h05	GlobeNewswire Inc.	Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial Results	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
15/05/2018	22h05	GlobeNewswire Inc.	Ohr Pharmaceutical Reports Fiscal Second Quarter 2018 Financial Results	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
13/03/2018	12h32	GlobeNewswire Inc.	Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
15/02/2018	23h15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
14/02/2018	22h05	GlobeNewswire Inc.	Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
06/12/2017	21h43	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
19/10/2017	00h03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.
16/05/2017	23h05	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OHRP	Ohr Pharmaceuticals, Inc.